Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Repligen is headquartered in Waltham, Massachusetts and employs approximately 2,000 people [2][3] - The company focuses on bioprocessing and has dual manufacturing capabilities in the U.S. and Europe [3] Financial Guidance - For 2025, Repligen projects sales to reach USD 733 million at the midpoint of their guidance [3] Vision and Strategy - The company's vision is to be the global leader in bioprocessing innovation, offering a diverse portfolio of data-driven solutions across various therapeutic modalities [4] - Innovation has been a key focus for Repligen over the past decade, positioning the company in a large bioprocessing market with significant competition [5]